Friday, 10 Oct 2025
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA
logo logo
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
  • 🔥
  • Trump
  • VIDEO
  • House
  • White
  • ScienceAlert
  • Trumps
  • Watch
  • man
  • Health
  • Season
Font ResizerAa
American FocusAmerican Focus
Search
  • World
  • Politics
  • Crime
  • Economy
  • Tech & Science
  • Sports
  • Entertainment
  • More
    • Education
    • Celebrities
    • Culture and Arts
    • Environment
    • Health and Wellness
    • Lifestyle
Follow US
© 2024 americanfocus.online – All Rights Reserved.
American Focus > Blog > Health and Wellness > ASH 2024: Roundup of news from first day of conference
Health and Wellness

ASH 2024: Roundup of news from first day of conference

Last updated: December 7, 2024 7:09 pm
Share
ASH 2024: Roundup of news from first day of conference
SHARE

The ASH 2024 conference brought exciting news in the field of hematology, with advancements in treatments for rare blood disorders such as immune thrombocytopenia (ITP) and sickle cell disease. Let’s dive into the highlights from the conference.

Sanofi presented promising results from a Phase 3 study of their drug rilzabrutinib for ITP, a condition where the body attacks and destroys its own platelets. The oral treatment showed improved platelet response in 65% of participants compared to a placebo, with a durable platelet response seen in 23% of patients. The drug also reduced bleeding episodes and fatigue. If approved, rilzabrutinib could become a new standard treatment for ITP, offering hope to patients who do not respond well to current therapies.

Novo Nordisk’s pill, etavopivat, showed potential in reducing severe pain crises in patients with sickle cell disease. The Phase 2 study demonstrated a 46% reduction in pain crises compared to a placebo, along with improvements in hemoglobin levels and fatigue. The drug belongs to a class that activates an enzyme to improve red blood cell health, offering a new approach to managing the debilitating effects of sickle cell disease.

Beam Therapeutics presented positive results from their CRISPR-based therapy, BEAM-101, for sickle cell disease. All seven patients treated with the therapy showed significant improvements, with increased levels of healthy fetal hemoglobin and decreased levels of sickled hemoglobin in their blood. While one patient experienced a fatal complication related to the treatment regimen, the overall outcomes were promising, showcasing the potential of CRISPR technology in treating genetic blood disorders.

In addition to these treatment advancements, research presented at the conference highlighted the importance of fertility preservation for sickle cell patients undergoing potentially curative therapies. Despite challenges and complications, fertility preservation procedures were deemed safe and viable for patients, provided they have access to the necessary services. With the rise of gene therapies for sickle cell disease, the need for insurance coverage for fertility services is becoming increasingly important to support patients seeking these treatments.

See also  At least 7 charged with gun possession during Chicago's Mexican Independence Day weekend; 5 are from the suburbs

Overall, the ASH 2024 conference showcased groundbreaking developments in hematology, offering new hope and possibilities for patients with rare blood disorders. Stay tuned for more updates on these exciting advancements in the field of blood diseases.

TAGGED:AshconferenceDayNewsRoundup
Share This Article
Twitter Email Copy Link Print
Previous Article ‘Reacher’ Season 3 Teaser Reveals February Premiere Date, New Villain ‘Reacher’ Season 3 Teaser Reveals February Premiere Date, New Villain
Next Article CalArts Staff and Faculty Move to Unionize CalArts Staff and Faculty Move to Unionize
Leave a comment

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Popular Posts

NFL offensive linemen Christmas gifts ranked: Do QBs, teams benefit from their generosity?

Offensive linemen in the NFL often have the most thankless job on the field. They…

December 31, 2024

13 Meaningful Ways to Show Someone They Matter

Making others feel important is a crucial aspect of building strong relationships and fostering a…

August 29, 2024

Trump Admin Proposes Rolling Back Coal Mining Safety Protections

The U.S. Department of the Interior’s Office of Surface Mining Reclamation and Enforcement recently made…

June 26, 2025

Anger, frustration after flooding in Canterbury

Reported by Tim Brown and Adam Burns of RNZ Residents in the Selwyn district of…

May 2, 2025

‘Harry Potter’ Star Stan Yanevski Hospitalized, Undergoes Emergency Surgery

'Harry Potter' Star Stan Yanevski Hospitalized for Emergency Surgery Actor Faces 'Inability to Breathe' Scare...…

May 23, 2025

You Might Also Like

STAT+: HHS employees to be fired as White House enacts mass terminations it blames on shutdown
Health and Wellness

STAT+: HHS employees to be fired as White House enacts mass terminations it blames on shutdown

October 10, 2025
Bari Weiss’ ‘How You Spend Your Working Hours’ Memo Raises Eyebrows at CBS News
Entertainment

Bari Weiss’ ‘How You Spend Your Working Hours’ Memo Raises Eyebrows at CBS News

October 10, 2025
Duck Dynasty’s Jessica Robertson Reacts to Daughter Priscilla’s Baby News
Entertainment

Duck Dynasty’s Jessica Robertson Reacts to Daughter Priscilla’s Baby News

October 10, 2025
No, circumcision doesn’t cause autism
Health and Wellness

No, circumcision doesn’t cause autism

October 10, 2025
logo logo
Facebook Twitter Youtube

About US


Explore global affairs, political insights, and linguistic origins. Stay informed with our comprehensive coverage of world news, politics, and Lifestyle.

Top Categories
  • Crime
  • Environment
  • Sports
  • Tech and Science
Usefull Links
  • Contact
  • Privacy Policy
  • Terms & Conditions
  • DMCA

© 2024 americanfocus.online –  All Rights Reserved.

Welcome Back!

Sign in to your account

Lost your password?